We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

225 hedge funds and large institutions have $1.86B invested in Dynavax Technologies in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 85 increasing their positions, 65 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

515% more call options, than puts

Call options by funds: $13.4M | Put options by funds: $2.18M

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

31% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 65

13% more capital invested

Capital invested by funds: $1.64B → $1.86B (+$219M)

5% more funds holding

Funds holding: 215225 (+10)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1.12% less ownership

Funds ownership: 98.95%97.84% (-1.1%)

Holders
225
Holders Change
+10
Holders Change %
+4.65%
% of All Funds
3.57%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
33
Increased
85
Reduced
65
Closed
20
Calls
$13.4M
Puts
$2.18M
Net Calls
+$11.2M
Net Calls Change
+$7.26M
Name Holding Trade Value Shares
Change
Change in
Stake
Lazard Asset Management
51
Lazard Asset Management
New York
$4.56M -$1.02M -72,825 -19%
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$4.53M -$763K -54,241 -15%
Swedbank
53
Swedbank
Sweden
$4.45M
Stifel Financial
54
Stifel Financial
Missouri
$4.45M +$31.5K +2,238 +0.7%
First Trust Advisors
55
First Trust Advisors
Illinois
$4.44M +$1.52M +108,397 +56%
Victory Capital Management
56
Victory Capital Management
Texas
$4.43M -$454K -32,245 -10%
TCM
57
Tang Capital Management
California
$4.43M
Thrivent Financial for Lutherans
58
Thrivent Financial for Lutherans
Minnesota
$4.41M +$49.4K +3,511 +1%
GC
59
Globeflex Capital
California
$4.3M -$93K -6,614 -2%
Swiss National Bank
60
Swiss National Bank
Switzerland
$4.17M +$38K +2,700 +1%
Barclays
61
Barclays
United Kingdom
$4.11M +$340K +24,156 +10%
JP Morgan Chase
62
JP Morgan Chase
New York
$3.85M +$24.6K +1,749 +0.7%
Citigroup
63
Citigroup
New York
$3.77M +$672K +47,771 +23%
CAM
64
Congress Asset Management
Massachusetts
$3.34M +$4.36K +310 +0.1%
AAA
65
Affinity Asset Advisors
New York
$2.95M +$2.81M +200,000 New
CS
66
Credit Suisse
Switzerland
$2.95M -$220K -15,673 -7%
JFG
67
Jefferies Financial Group
New York
$2.89M +$2.11M +150,000 +328%
EF
68
Empowered Funds
Pennsylvania
$2.76M +$43.2K +3,070 +2%
Axa
69
Axa
France
$2.69M
TI
70
Trexquant Investment
Connecticut
$2.58M +$1.32M +94,205 +117%
Two Sigma Investments
71
Two Sigma Investments
New York
$2.54M -$5.14M -365,272 -68%
Zurich Cantonal Bank
72
Zurich Cantonal Bank
Switzerland
$2.53M -$2.98M -211,962 -55%
UBS AM
73
UBS AM
Illinois
$2.38M +$418K +29,714 +23%
Public Sector Pension Investment Board (PSP Investments)
74
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.35M -$744K -52,914 -25%
Prudential Financial
75
Prudential Financial
New Jersey
$2.23M -$190K -13,534 -8%

DVAX Hedge Fund Activity: Q3 2023 in Review

225 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2023, worth a combined $1.86B — up 13% from $1.64B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new DVAX positions and 20 closed out — a net gain of 13 holders — while 85 added to existing stakes and 65 trimmed.

The largest buyer was BlackRock, adding an estimated $29M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $34.9M sold.

  • 225 institutional investors held Dynavax Technologies (DVAX) as of Q3 2023, up from 215 in Q2 2023.
  • Funds reported $1.86B of Dynavax Technologies stock for Q3 2023, up 13% quarter-over-quarter.
  • 33 funds opened new Dynavax Technologies positions in Q3 2023 and 20 closed out, a net change of +13 holders.
  • The largest Dynavax Technologies buyer in Q3 2023 was BlackRock, an estimated $29M added.
  • The largest Dynavax Technologies seller in Q3 2023 was PFM Health Sciences, an estimated $34.9M sold.

Based on aggregated 13F filings for Q3 2023.